Effects of Apatinib on the “Stemness” of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms by Bin Yang, Yan Wang, Zhuoying Chen, Yi-Ming Feng, Liang-Liang Shi

“…To investigate the effects of Apatinib on the “stemness” of lung cancer cells in vivo and to explore its related mechanisms. …”
Get full text

Factors Affecting the Survival of Patients with Oligometastatic Non-Small-Cell Lung Cancer: A Meta-Analysis by Yu Shi, Jianxin Yang, Ninghua Yao, Minghai Shao, Wenxiu Ding, Wanrong Jiang, Xinchen Sun

“…The aim was to investigate the potential factors related with overall survival of oligometastatic non-small-cell lung cancer (NSCLC) patients. Methods. A literature search was conducted in databases including PubMed, Embase, and Cochrane library up to March 2017. …”
Get full text

Composition of the sputum bacterial microbiome of patients with different pathomorphological forms of non-small-cell lung cancer by V. G. Druzhinin, E. D. Baranova, P. S. Demenkov, L. V. Matskova, A. V. Larionov

Subjects: “…non-small cell lung cancer…”
Get full text

Comparison of tissue-based and plasma-based testing for mutation in non–small cell lung cancer patients by Yoon Kyung Kang, Dong Hoon Shin, Joon Young Park, Chung Su Hwang, Hyun Jung Lee, Jung Hee Lee, Jee Yeon Kim, JooYoung Na

Subjects: Get full text

Support Vector Machine – Recursive Feature Elimination for Feature Selection on Multi-omics Lung Cancer Data by Nuraina Syaza Azman, Azurah A Samah, Ji Tong Lin, Hairudin Abdul Majid, Zuraini Ali Shah, Nies Hui Wen, Chan Weng Howe

“…The study focuses on mitigating the curse of dimensionality by implementing Support Vector Machine – Recursive Feature Elimination (SVM-RFE) as the selected feature selection method in the lung cancer (LUSC) multi-omics dataset integrated from three single omics dataset comprising genomics, transcriptomics and epigenomics, and assess the quality of the selected feature subsets using SDAE and VAE deep learning classifiers. …”
Get full text

Volatile Organic Compounds for the Prediction of Lung Cancer by Using Ensembled Machine Learning Model and Feature Selection by Divya Khanna, Arun Kumar, Shahid Ahmad Bhat

Subjects: Get full text

Consensus on Rehabilitation Assessment and Treatment for Full-Cycle Rehabilitation of Elderly Lung Cancer by Rehabilitation and Respiratory Experts by Jia Jie, ², Chen Xin³, He Jing⁴, Dong Anqin⁵, Ding Yipeng⁶, Liao Weijing⁷, Zheng Jiejao⁸, Yu Binbin⁹, Chen Zuobing ⁰, Fang Yuan, Yao Liqing ², Zhu Yiping ³

Subjects: “…Elderly lung cancer…”
Get full text

Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study by Naoki Furuya, Yukari Tsubata, Takamasa Hotta, Toshihide Yokoyama, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe

Subjects: Get full text

Repeated ionizing radiation exposure induces TRIP13 expression, conferring radioresistance in lung cancer cells by Wenqing Liu, Qijing Lei, Ans M. M. van Pelt, Geert Hamer

Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text

Investigating lung cancer microenvironment from cell segmentation of pathological image and its application in prognostic stratification by Xu Zhang, Zi-Han Zhang, Yong-Min Liu, Shi-Lei Zhao, Xu-Tong Zhao, Li-Zhi Zhang, Chun-Dong Gu, Yi Zhao

“…Abstract Lung cancer, particularly adenocarcinoma, ranks high in morbidity and mortality rates worldwide, with a relatively low five-year survival rate. …”
Get full text

Synergistic therapeutic efficacy and safety of anlotinib and sequential radiotherapy in advanced central squamous-cell lung cancer by Nan Wei, Xuan Wu, Xiaoju Zhang

Get full text

Fine-Grained Lung Cancer Classification from PET and CT Images Based on Multidimensional Attention Mechanism by RuoXi Qin, Zhenzhen Wang, LingYun Jiang, Kai Qiao, Jinjin Hai, Jian Chen, Junling Xu, Dapeng Shi, Bin Yan

“…Lung cancer ranks among the most common types of cancer. …”
Get full text

LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer by Théophile Ponchel, Emma Loeffler, Julien Ancel, Audrey Brisebarre, Nathalie Lalun, Véronique Dalstein, Anne Durlach, Gaëtan Deslée, Stéphane Dedieu, Myriam Polette, Béatrice Nawrocki-Raby

“…The tumor suppressor fragile histidine triad (FHIT) is frequently lost in non-small cell lung cancer (NSCLC). We previously showed that a down-regulation of FHIT causes an up-regulation of the activity of HER2 associated to an epithelial-mesenchymal transition (EMT) and that lung tumor cells harboring a FHITlow/pHER2high phenotype are sensitive to anti-HER2 drugs. …”
Get full text

Impact of the COVID-19 pandemic on lung cancer diagnosis in northern Poland-addressing the COVID-19 debt. by Anna Romaszko-Wojtowicz, Anna Doboszyńska, Anna Piechnik, Krzysztof Kuziemski, Dariusz Szplit, Szczepan Cofta, Katarzyna Glińska-Lewczuk

“…<h4>Introduction</h4>Lung cancer, one of the leading causes of death due to neoplasms, requires prompt diagnosis and immediate treatment. …”
Get full text

Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2 by Bin Ke, Ting Wei, Yuanyuan Huang, Yuxin Gong, Gang Wu, Junfang Liu, Xiaoting Chen, Lin Shi

“…Treatment with cisplatin (DDP) is one of the standard therapies used to treat non-small-cell lung cancer (NSCLC) and fundamentally causes resistance in cancer cells, which eventually poses as an obstacle to the efficacy of chemotherapy in NSCLC. …”
Get full text

Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab by Panagiotis I. Georgianos, Vasilios Vaios, Eleni Leontaridou, Georgia Karayannopoulou, Triantafyllia Koletsa, Athanasios Sioulis, Elias V. Balaskas, Pantelis E. Zebekakis

“…We present the case of a 60-year-old man with a history of non-small cell lung cancer, who developed acute kidney injury (AKI) approximately 3.5 months after initiation of immunotherapy with nivolumab. …”
Get full text

Systematic review and meta‑analysis of factors predicting postoperative lung function after lung cancer resection by Hongling Wang, Lihong He, Xiaoyun Hu, Gongxue Xian

Subjects: Get full text

Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations by Jason C.S. Ho, K.M. Cheung

Subjects: “…Non-small cell lung cancer…”
Get full text

Relationship between gender and perioperative clinical features in lung cancer patients who underwent VATS lobectomy by Wei Chen, Qiangqiang Zheng, Yi Shen, Min Liang, Yang Yuan, Yusong Lu, Yunfeng Zhou

Subjects: “…Lung cancer…”
Get full text

MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer by Zhiguang Liu, Xinlian Wang, Liqiang Cao, Xiaowei Yin, Qian Zhang, Lan Wang

“…This research aimed to explore the biological role and mechanisms of miR-877-5p, which may help patients with non-small-cell lung cancer (NSCLC) find effective therapeutic targets. …”
Get full text